Abivax (ABVX) Invested Capital (2021 - 2025)
Historic Invested Capital for Abivax (ABVX) over the last 5 years, with Q3 2025 value amounting to $32.8 million.
- Abivax's Invested Capital changed N/A to $32.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.4 million, marking a year-over-year increase of 11668.11%. This contributed to the annual value of $121.8 million for FY2024, which is 4617.56% up from last year.
- As of Q3 2025, Abivax's Invested Capital stood at $32.8 million.
- In the past 5 years, Abivax's Invested Capital registered a high of $121.8 million during Q4 2024, and its lowest value of $2.7 million during Q2 2024.
- In the last 5 years, Abivax's Invested Capital had a median value of $41.8 million in 2022 and averaged $49.0 million.
- Its Invested Capital has fluctuated over the past 5 years, first plummeted by 2788.62% in 2022, then surged by 49910.74% in 2025.
- Quarter analysis of 5 years shows Abivax's Invested Capital stood at $70.5 million in 2021, then dropped by 27.89% to $50.8 million in 2022, then surged by 63.16% to $82.9 million in 2023, then surged by 46.96% to $121.8 million in 2024, then plummeted by 73.04% to $32.8 million in 2025.
- Its Invested Capital stands at $32.8 million for Q3 2025, versus $16.0 million for Q2 2025 and $14.7 million for Q1 2025.